News Archives - Page 121 of 1183 - BioHealth Innovation

News

October 17, 2022

Gilead and MacroGenics Announce Oncology Collaboration to Develop Bispecific Antibodies | Business Wire

FOSTER CITY, Calif. & ROCKVILLE, Md.--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ: GILD) and MacroGenics (NASDAQ: MGNX) today announced an exclusive option…

admin

Love0

News

October 17, 2022

Crab Trap Winner Sherine Chan, Ph.D. or Neuronene, joins Rich Bendis on BioTalk

Neuroene Therapeutics Co-Founder and CEO Sherine Chan, Ph.D., joins Rich Bendis on BioTalk to discuss winning the 7th Annual BioHealth…

admin

Love0

News

October 17, 2022

Maryland Inno – Baltimore startup Vita Therapeutics raises $31M to advance treatment for genetic diseases

Baltimore's Vita Therapeutics announced the completion of a $31 million series B funding round on Wednesday, propelling the cell therapy…

admin

Love0

News

October 17, 2022

Is this really the second-best time ever to raise early-stage capital? | TechCrunch

“The 2022 venture capital market” is nearly a misnomer, as each quarter that passes seems to bring with it a…

admin

Love0

News

October 17, 2022

Meet The NIA Entrepreneur-in-Residence (EIR)

We are so thankful for our Entrepreneurs-in-Residence (EIRs), who provide free business development guidance and counsel to assist #SmallBiz awardees…

admin

Love0

News

October 17, 2022

Venture-Capital Firms Buy Up Public Tech Stocks as Startup Market Stalls – WSJ

Venture-capital firms are jumping into the stock market, buying up battered shares in publicly traded tech companies at a time…

admin

Love0

News

October 13, 2022

Diagnostics firm Bio-Rad in talks to merge with Qiagen – WSJ | Reuters

Oct 10 (Reuters) - California-based diagnostics company Bio-Rad Laboratories (BIO.N) is in talks to merge with Qiagen NV (QIA.DE), the…

admin

Love0

News

October 13, 2022

BARDA Continues to Develop Public-Private Partnerships to Protect the Country · BioBuzz

Biotech and life sciences companies can benefit from partnering with the federal government in many ways, from funding to increased…

admin

Love0

News

October 13, 2022

Dr. Arti Santhanam: A Collaborative Scientist’s Passion Helps Build a Top-Five Tech-Based Entrepreneurial Community – Worlds Leaders

What does the Zulu word “ubuntu” have to do with a successful science and tech fund at Maryland’s TEDCO? To…

admin

Love0

News

October 13, 2022

Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants

Oct 12, 2022 Homologous boosting with the prototype Novavax COVID-19 vaccine induced robust antibody titers for Omicron BA.1, BA.2, and…

admin

Love0

News

Gilead and MacroGenics Announce Oncology Collaboration to Develop Bispecific Antibodies | Business Wire

Crab Trap Winner Sherine Chan, Ph.D. or Neuronene, joins Rich Bendis on BioTalk

Maryland Inno – Baltimore startup Vita Therapeutics raises $31M to advance treatment for genetic diseases

Is this really the second-best time ever to raise early-stage capital? | TechCrunch

Meet The NIA Entrepreneur-in-Residence (EIR)

Venture-Capital Firms Buy Up Public Tech Stocks as Startup Market Stalls – WSJ

Diagnostics firm Bio-Rad in talks to merge with Qiagen – WSJ | Reuters

BARDA Continues to Develop Public-Private Partnerships to Protect the Country · BioBuzz

Dr. Arti Santhanam: A Collaborative Scientist’s Passion Helps Build a Top-Five Tech-Based Entrepreneurial Community – Worlds Leaders

Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants

About BioHealth Innovation

Contact

Connect

News

About BioHealth Innovation

Contact

Connect

Search